Bollard Group LLC Portfolio
Auto-discovered active 13F filer.
SEC 13F CIK: 0001556218
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q4 2023 · 269 positions · Total reported value $2.79B · Top-10 concentration 75.5% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 25.4% · 4 new · 68 cut · 6 exited
Active Share (vs S&P 500): 68.7% · vs QQQ: 80.6% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): +3.3% · vs SPY +1.2% · Prev Value $3.05B — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): -0.2% · vs SPY -2.4% · Latest Value $2.29B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q4 2023 13F filing, Bollard Group LLC disclosed 269 equity positions with a combined reported value of $2.79B. The filing implies a focused portfolio: its ten largest positions account for 75.5% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / High Turnover.
The largest disclosed positions as of Q4 2023 were BSX ($1.29B), IT ($172.30M), LLY ($146.37M). By sector, the heaviest allocations are Health Care 54.1%, Consumer Discretionary 12.5%. Versus the prior quarter, allocation shifted toward Consumer Discretionary (+1.5pp) and away from Health Care (-0.6pp), Other (-1.2pp).
Versus the prior quarter, Bollard Group LLC opened 4 new positions, trimmed 68 and fully exited 6, a turnover rate of 25.4% of positions. The portfolio's overlap with the prior quarter was 82% of names.
The largest new positions opened in Q4 2023 were DINO ($10.98M), PRME ($3.20M), VLTO ($101.00K).
Of the 6 positions fully exited versus the prior quarter, the largest were HEP ($13.68M), COF ($1.45M), NVO ($52.00K).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q4 2023)
- DINO HF SINCLAIR CORP · $10.98M
- PRME PRIME MEDICINE INC · $3.20M
- VLTO VERALTO CORP · $101.00K
- SOXX ISHARES SEMICONDUCTOR · $4.00K
Fully Exited (vs previous quarter)
- HEP HOLLY ENERGY PARTNERS L P · prev qtr: $13.68M
- COF CAPITAL ONE FINANCIAL CORP · prev qtr: $1.45M
- NVO NOVO-NORDISK A S · prev qtr: $52.00K
- BTI Brit Amern Tob Plc Sponsored C · prev qtr: $31.00K
- SAP SAP SE · prev qtr: $27.00K
- STM STMICROELECTRONICS N V · prev qtr: $17.00K
- SAIA SAIA INC · prev qtr: $14.00K
- SM SM ENERGY COMPANY · prev qtr: $12.00K
Insider Transactions (Form 4)
Latest Bollard Group LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Bollard Group LLC, based in Boston, MA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 303 positions worth $3.05B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Firm Snapshot
- Headquarters: BOSTON, MA, United States
- SEC registration: 801-72749 (status: Approved), registered 2011-10-14
- Regulatory AUM (Form ADV): $6.49B as of 2026-07-15
- Client mix (by RAUM): individual investors 79%, pension and profit-sharing plans 21%
- Manages 91 private funds, of which 3 hedge funds
- Website: bollard.com
Portfolio Structure
- 303 positions · $3.05B reported value (Q2 2026)
- Top 10 holdings = 65.8% of reported value
- Largest position: BSX (BOSTON SCIENTIFIC CORP) at 25.8%
- Average position size: $10.06M
Sector Tilt
- Health Care 28.5%
- Information Technology 12.3%
- Utilities 12.2%
- (classified holdings cover 93% of value)
Quarterly Activity
- Q2 2026: 23 new, 110 added, 50 reduced, 19 exited
- 120 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
22.39M | $1.29B | 46.40% | Reduce | |
| 2 |
|
381.94K | $172.30M | 6.18% | Hold | |
| 3 |
|
251.09K | $146.37M | 5.25% | Hold | |
| 4 |
|
755.10K | $114.73M | 4.11% | Reduce | |
| 5 |
|
282.12K | $106.09M | 3.80% | Add | |
| 6 |
|
757.69K | $65.21M | 2.34% | Add | |
| 7 |
|
196.55K | $58.11M | 2.08% | Hold | |
| 8 |
|
104.92K | $55.69M | 2.00% | Hold | |
| 9 |
|
748.92K | $52.59M | 1.89% | Add | |
| 10 |
|
514.20K | $41.76M | 1.50% | Add | |
| 11 |
|
1.49M | $39.30M | 1.41% | Add | |
| 12 |
|
439.74K | $30.83M | 1.10% | Add | |
| 13 |
|
64.21K | $25.68M | 0.92% | Hold | |
| 14 |
|
302.40K | $25.05M | 0.90% | Hold | |
| 15 |
|
405.12K | $24.77M | 0.89% | Add | |
| 16 |
|
248.42K | $24.18M | 0.87% | Add | |
| 17 |
|
139.22K | $23.68M | 0.85% | Reduce | |
| 18 |
|
252.21K | $23.52M | 0.84% | Reduce | |
| 19 |
|
236.47K | $22.95M | 0.82% | Reduce | |
| 20 |
|
178.29K | $19.44M | 0.70% | Add | |
| 21 |
|
290.42K | $17.11M | 0.61% | Add | |
| 22 |
|
103.48K | $16.31M | 0.58% | Hold | |
| 23 |
|
107.55K | $16.04M | 0.57% | Add | |
| 24 |
|
132.37K | $15.36M | 0.55% | Add | |
| 25 |
|
952.39K | $14.43M | 0.52% | Add | |
| 26 |
|
758.15K | $13.37M | 0.48% | Add | |
| 27 |
|
83.11K | $13.03M | 0.47% | Reduce | |
| 28 |
|
96.38K | $12.83M | 0.46% | Add | |
| 29 |
|
316.46K | $11.62M | 0.42% | Add | |
| 30 |
|
197.51K | $10.98M | 0.39% | New | |
| 31 |
|
97.91K | $10.78M | 0.39% | Add | |
| 32 |
|
298.77K | $10.58M | 0.38% | Add | |
| 33 |
|
740.25K | $10.21M | 0.37% | Add | |
| 34 |
|
228.33K | $8.22M | 0.29% | Reduce | |
| 35 |
|
61.45K | $8.19M | 0.29% | Reduce | |
| 36 |
|
211.36K | $7.75M | 0.28% | Add | |
| 37 |
|
58.97K | $7.67M | 0.28% | Add | |
| 38 |
|
221.25K | $7.45M | 0.27% | Reduce | |
| 39 |
|
169.64K | $6.98M | 0.25% | Add | |
| 40 |
|
27.69K | $6.80M | 0.24% | Hold | |
| 41 |
|
125.98K | $6.46M | 0.23% | Reduce | |
| 42 |
|
28.04K | $6.24M | 0.22% | Hold | |
| 43 |
|
136.05K | $5.75M | 0.21% | Add | |
| 44 |
|
25.55K | $5.75M | 0.21% | Hold | |
| 45 |
|
13.02K | $5.69M | 0.20% | Hold | |
| 46 |
|
30.97K | $5.26M | 0.19% | Reduce | |
| 47 |
|
13.19K | $5.09M | 0.18% | Reduce | |
| 48 |
|
40.28K | $4.89M | 0.17% | Reduce | |
| 49 |
|
50.63K | $4.76M | 0.17% | Reduce | |
| 50 |
|
17.09K | $4.45M | 0.16% | Add | |
FAQ
What did Bollard Group LLC buy in 2023-Q4?
In its 2023-Q4 13F filing, Bollard Group LLC reported 269 equity positions worth $2.79B in aggregate; its largest disclosed positions were BSX ($1.29B), IT ($172.30M), LLY ($146.37M).
How large is Bollard Group LLC's portfolio?
Bollard Group LLC reported $2.79B of long equity holdings across 269 positions as of 2023-Q4. Top-10 holdings account for 75.5% of reported value.
What is Bollard Group LLC's investment style?
HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.